Prevention of contrast-induced nephropathy (CIN) in interventional radiology practice

Seminars in Interventional Radiology

Volumn 27, Issue 4, 2010, Pages 348-359

  Gupta, Rajan K ^a   Bang, Tami J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

CIN; Contrast media; Contrast induced nephropathy; Prevention; Renal failure

Indexed keywords

EID: 78349299464     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0030-1267860     Document Type: Article

References (50)

1. Hou S H., Bushinsky D A., Wish J B., Cohen J J., Harrington J T. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983 74 (2) 243-248
2. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002 39 (5) 930-936
3. Rihal C S., Textor S C., Grill D E. et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002 105 (19) 2259-2264
4. Levy E M., Viscoli C M., Horwitz R I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996 275 (19) 1489-1494
5. Ellis J H., Cohan R H. Reducing the risk of contrast-induced nephropathy: a perspective on the controversies. AJR Am J Roentgenol 2009 192 (6) 1544-1549
6. Segal A J., Ellis J H. et al. ACR, Manual on Contrast Media: Version 6. 2008. Available at: http://www.acr.org/contrast-manual Accessed November 1, 2009
7. Gleeson T G., Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol 2004 183 (6) 1673-1689
8. Kolonko A, Kokot F, Wiecek A. Contrast-associated nephropathyold clinical problem and new therapeutic perspectives. Nephrol Dial Transplant 1998 13 (3) 803-806
9. Goldfarb S, McCullough P A., McDermott J, Gay S B. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc 2009 84 (2) 170-179
10. Katzberg R W., Lamba R. Contrast-induced nephropathy after intravenous administration: fact or fiction? Radiol Clin North Am 2009 47 (5) 789-800, v v
11. Newhouse J H., Kho D, Rao Q A., Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 2008 191 (2) 376-382
12. Cramer B C., Parfrey P S., Hutchinson T A. et al. Renal function following infusion of radiologic contrast material. A prospective controlled study. Arch Intern Med 1985 145 (1) 87-89
13. Heller C A., Knapp J, Halliday J, O'Connell D, Heller R F. Failure to demonstrate contrast nephrotoxicity. Med J Aust 1991 155 (5) 329-332
14. Rao Q A., Newhouse J H. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006 239 (2) 392-397
15. Rudnick M R., Kesselheim A, Goldfarb S. Contrast-induced nephropathy: how it develops, how to prevent it. Cleve Clin J Med 2006 73 (1) 75-80 83-87
16. Schweiger M J., Chambers C E., Davidson C J. et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007 69 (1) 135-140
17. McCullough P A., Wolyn R, Rocher L L., Levin R N., O'Neill W W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997 103 (5) 368-375
18. Barrett B J., Parfrey P S. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006 354 (4) 379-386
19. Benko A, Fraser-Hill M, Magner P et al, Canadian Association of Radiologists. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy. Can Assoc Radiol J 2007 58 (2) 79-87
20. Ellis J H., Cohan R H. Prevention of contrast-induced nephropathy: an overview. Radiol Clin North Am 2009 47 (5) 801-811, v v
21. Rudnick M R., Goldfarb S, Wexler L et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995 47 (1) 254-261
22. McCullough P A., Sandberg K R. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003 4 (Suppl 5) S3-S9
23. Thomsen H S., Morcos S K. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCTa pooled analysis of two randomized trials. Eur Radiol 2009 19 (4) 891-897
24. Thomsen H S., Morcos S K. Radiographic contrast media. BJU Int 2000 86 (Suppl 1) 1-10
25. Morcos S K. Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media? Clin Radiol 2009 64 (5) 468-472
26. Taliercio C P., Vlietstra R E., Ilstrup D M. et al. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol 1991 17 (2) 384-390
27. Manke C, Marcus C, Page A, Puey J, Batakis O, Fog A. Pain in femoral arteriography. A double-blind, randomized, clinical study comparing safety and efficacy of the iso-osmolar iodixanol 270 mgI/ml and the low-osmolar iomeprol 300 mgI/ml in 9 European centers. Acta Radiol 2003 44 (6) 590-596
28. Justesen P, Downes M, Grynne B H., Lang H, Rasch W, Seim E. Injection-associated pain in femoral arteriography: a European multicenter study comparing safety, tolerability, and efficacy of iodixanol and iopromide. Cardiovasc Intervent Radiol 1997 20 (4) 251-256
29. Pugh N D., Sissons G R., Ruttley M S., Berg K J., Nossen J O., Eide H. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol 1993 47 (2) 96-99
30. Verow P, Nossen J O., Sheppick A, Kjaersgaard P. A comparison of iodixanol with iopamidol in aorto-femoral angiography. Br J Radiol 1995 68 (813) 973-978
31. Cigarroa R G., Lange R A., Williams R H., Hillis L D. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989 86 (6 Pt 1) 649-652
32. Freeman R V., O'Donnell M, Share D et al, Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002 90 (10) 1068-1073
33. Laskey W K., Jenkins C, Selzer F et al, NHLBI Dynamic Registry Investigators. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007 50 (7) 584-590
34. Mueller C, Buerkle G, Buettner H J. et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002 162 (3) 329-336
35. Merten G J., Burgess W P., Gray L V. et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004 291 (19) 2328-2334
36. Brar S S., Shen A Y., Jorgensen M B. et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 2008 300 (9) 1038-1046
37. Hogan S E., L'Allier P, Chetcuti S et al. Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J 2008 156 (3) 414-421
38. Navaneethan S D., Singh S, Appasamy S, Wing R E., Sehgal A R. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 2009 53 (4) 617-627
39. From A M., Bartholmai B J., Williams A W., Cha S S., Pflueger A, McDonald F S. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol 2008 3 (1) 10-18
40. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000 343 (3) 180-184
41. Fishbane S. N-acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 2008 3 (1) 281-287
42. Amini M, Salarifar M, Amirbaigloo A, Masoudkabir F, Esfahani F. N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial. Trials 2009 10 45
43. Gonzales D A., Norsworthy K J., Kern S J. et al. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med 2007 5 32
44. Marenzi G, Assanelli E, Marana I et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006 354 (26) 2773-2782
45. Vaitkus P T., Brar C. N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses. Am Heart J 2007 153 (2) 275-280
46. Hoffmann U, Fischereder M, Krger B, Drobnik W, Krmer B K. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004 15 (2) 407-410
47. Poletti P A., Saudan P, Platon A et al. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol 2007 189 (3) 687-692
48. Baker C S., Wragg A, Kumar S, De Palma R, Baker L R., Knight C J. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 2003 41 (12) 2114-2118
49. Vogt B, Ferrari P, Schnholzer C et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001 111 (9) 692-698
50. Marenzi G, Marana I, Lauri G et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003 349 (14) 1333-1340